Compounds > rhodioloside
Page last updated: 2024-09-04

rhodioloside and Cirrhosis

rhodioloside has been researched along with Cirrhosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Liang, Y; Liu, X; Lu, L; Qu, B; Zhang, C; Zheng, K1
Cheng, W; Li, W; Pei, T; Wang, L; Xiao, W; Yan, S; Yang, S; Zeng, Y1
Ji, X; Lan, Y; Li, Y; Ma, J; Ma, L; Wang, A1
Chen, P; Han, B; Liu, J; Ruan, H; Wu, P; Yimei, D; Zhang, M1
Guo, Y; Li, R; Yan, T; Zhang, X; Zhang, Y; Zhu, L1

Reviews

1 review(s) available for rhodioloside and Cirrhosis

ArticleYear
Salidroside in the Treatment of NAFLD/NASH.
    Chemistry & biodiversity, 2022, Volume: 19, Issue:12

    Topics: Fibrosis; Glucosides; Humans; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease

2022

Other Studies

4 other study(ies) available for rhodioloside and Cirrhosis

ArticleYear
Salidroside Alleviates Renal Fibrosis in SAMP8 Mice by Inhibiting Ferroptosis.
    Molecules (Basel, Switzerland), 2022, Nov-19, Volume: 27, Issue:22

    Topics: Animals; Ferroptosis; Fibrosis; Glucosides; Kidney Diseases; Mice

2022
Integrating network pharmacology and experimental verification to explore the mechanisms of salidroside against myocardial fibrosis.
    Biochemical and biophysical research communications, 2023, 10-15, Volume: 677

    Topics: Animals; beta Catenin; Fibrosis; Network Pharmacology; Rats; Smad3 Protein; Transforming Growth Factor beta1; Wnt Signaling Pathway

2023
Protective effects of Salidroside on cardiac function in mice with myocardial infarction.
    Scientific reports, 2019, 12-02, Volume: 9, Issue:1

    Topics: Animals; Apoptosis; Cardiotonic Agents; Coronary Vessels; Cytokines; Disease Models, Animal; Fibrosis; Glucosides; Heart; Ligation; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Phenols; Ventricular Remodeling

2019
Salidroside Ameliorates Renal Interstitial Fibrosis by Inhibiting the TLR4/NF-κB and MAPK Signaling Pathways.
    International journal of molecular sciences, 2019, Mar-04, Volume: 20, Issue:5

    Topics: Cadherins; Cell Line; Cytokines; Epithelial-Mesenchymal Transition; Extracellular Matrix; Fibrosis; Gene Expression Regulation; Glucosides; Humans; Kidney; Kidney Diseases; Kidney Tubules, Proximal; MAP Kinase Signaling System; NF-kappa B; Phenols; Rhodiola; Toll-Like Receptor 4

2019